K251381 is an FDA 510(k) clearance for the Ceribell Instant EEG Headcap (Small: C251, Medium: C252). This device is classified as a Electrode, Cutaneous (Class II - Special Controls, product code GXY).
Submitted by Ceribell, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on October 31, 2025, 182 days after receiving the submission on May 2, 2025.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1320.
| 510(k) Number | K251381 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | May 02, 2025 |
| Decision Date | October 31, 2025 |
| Days to Decision | 182 days |
| Submission Type | Abbreviated |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GXY - Electrode, Cutaneous |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.1320 |